MedTrace Logo

Monitoring and Evaluation of Micronutrients (Sprinkles) Project

NCT00659061 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 610

Last updated 2018-02-01

Study results available
· View outcomes & findings →

Summary

The purpose of this study is 1) to evaluate the effectiveness in reducing anemia among children 6-24 months of age by providing daily micronutrient Sprinkles through the Government of Pakistan's Lady Health Worker program; 2) to assist in the monitoring the National Sprinkles Pilot Project.

Conditions

Interventions

DIETARY_SUPPLEMENT

SPRINKLES

Sprinkles is a multiple micronutrient fortificant. It is packed as a single serving sachets each containing micro encapsulated iron (12.5 mg), zinc (7.5 mg), vitamin C (30 mg), vitamin A (300 µg), vitamin D (5 µg), folic acid (150 µg) and iodine (90µg). Two month supply of the Sprinkle sachet along with advice on its benefits as well as its appropriate use will be given by the LHWs. The LHWs will also provide their age-appropriate nutritional advice as per their regular door to door community services.

BEHAVIORAL

Nutrition education

Nutrition education will be provided by LHWs as per their regular routine monthly door to door community services

Sponsors & Collaborators

  • Micronutrient Initiative

    collaborator OTHER

  • M/S SEBCON

    collaborator OTHER

  • Pakistan Ministry of Health

    collaborator OTHER_GOV

  • National Programme of Family Planning and Primary Health Care

    collaborator UNKNOWN

  • Aga Khan University

    lead OTHER

Principal Investigators

  • Zulfiqar A Bhutta, MD, PhD · Aga Khan University

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
18 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2008-04-30
Completion
2008-05-31

Countries

  • Pakistan

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00659061 on ClinicalTrials.gov